Sphera Funds Management Ltd. Eledon Pharmaceuticals, Inc. Transaction History
Sphera Funds Management Ltd.
- $683 Million
- Q2 2024
A detailed history of Sphera Funds Management Ltd. transactions in Eledon Pharmaceuticals, Inc. stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 1,297,021 shares of ELDN stock, worth $6.43 Million. This represents 0.5% of its overall portfolio holdings.
Number of Shares
1,297,021Holding current value
$6.43 Million% of portfolio
0.5%Shares
1 transactions
Others Institutions Holding ELDN
# of Institutions
34Shares Held
18.3MCall Options Held
0Put Options Held
0-
Bvf Inc San Francisco, CA6.29MShares$31.2 Million0.51% of portfolio
-
Armistice Capital, LLC New York, NY2.34MShares$11.6 Million0.08% of portfolio
-
Zimmer Partners, LP New York, NY2.11MShares$10.5 Million0.11% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY1.5MShares$7.44 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.1MShares$5.48 Million0.0% of portfolio
About Eledon Pharmaceuticals, Inc.
- Ticker ELDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,756,800
- Market Cap $68.2M
- Description
- Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...